FREPP/SEPP Kit containing 1 FREPP (povidone iodine 2% aqueous solution), Net 1.1 mL and 1 SEPP (p...

FDA Drug Recall #D-229-2013 — Class II — March 4, 2013

Recall Summary

Recall Number D-229-2013
Classification Class II — Moderate risk
Date Initiated March 4, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm CareFusion 213, LLC
Location El Paso, TX
Product Type Drugs
Quantity 544,500 kits

Product Description

FREPP/SEPP Kit containing 1 FREPP (povidone iodine 2% aqueous solution), Net 1.1 mL and 1 SEPP (povidone iodine 10% USP), Net 0.67 mL per kit, packaged in 20 kits per carton, Cat. No 260288, NDC 54365-202-99, CareFusion, Leawood, KS 66211.

Reason for Recall

Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.

Distribution Pattern

Nationwide, Puerto Rico, Virgin Islands, Malaysia, and United Kingdom

Lot / Code Information

All lots with expiry between 07/11 to 08/14.

Other Recalls from CareFusion 213, LLC

Recall # Classification Product Date
D-0243-2026 Class II BD ChloraPrep" Triple Swabsticks (Chlorhexidine... Dec 17, 2025
D-0441-2025 Class II BD ChloraPrep Clear, 2% x/v chlorhexidine gluco... May 15, 2025
D-0259-2025 Class I BD ChloraPrep Clear 1mL Applicators, 2% w/v chl... Feb 14, 2025
D-1168-2023 Class II BD ChloraPrep Clear, 2% w/v chlorhexidine gluco... Aug 25, 2023
D-0373-2021 Class I BD ChloraPrep Hi-Lite Orange 26 mL Applicator (... Apr 20, 2021

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.